Other Clinical Trial - UDFF Performance Evaluation ((Ultrason Derived Fat

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02248311` - "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population	N/A
Completed	`NCT01277237` - The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease	Phase 3
Active, not recruiting	`NCT04442620` - Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity	N/A
Completed	`NCT01999101` - Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients	Phase 2
Completed	`NCT01327443` - Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease	N/A
Active, not recruiting	`NCT01482065` - The Sleep, Liver Evaluation and Effective Pressure Study	N/A
Completed	`NCT03135873` - Mastiha Treatment for Obese With NAFLD Diagnosis	N/A
Completed	`NCT02686476` - Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes	N/A
Completed	`NCT02820285` - Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH	N/A
Completed	`NCT01556113` - Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease	N/A
Terminated	`NCT02134522` - The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease	N/A
Completed	`NCT01553500` - Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease	Phase 2
Completed	`NCT05426382` - A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease	N/A
Completed	`NCT03300661` - Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine	N/A
Not yet recruiting	`NCT02178839` - The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease	N/A
Recruiting	`NCT02038387` - Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)	N/A
Completed	`NCT01874249` - Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease	N/A
Completed	`NCT01634048` - The Effect of Protein-enriched Diet on Body Composition and Appetite	N/A
Completed	`NCT01966627` - Genetics of Fatty Liver Disease in Children	N/A
Terminated	`NCT01842282` - Amlexanox for Type 2 Diabetes and Obesity	Phase 2

NCT number	NCT06080386
Study type	Observational
Source	University Hospital, Angers
Contact	Christophe Aubé
Phone	+33 2 41 35 42 81
Email	chaube@chu-angers.fr
Status	Recruiting
Phase
Start date	March 1, 2022
Completion date	October 15, 2023

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction) — UDFF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms